GgoogleAU first seen 6 d ago, last 6 d ago, peak #2
Retatrutide, the new weight-loss drug, draws attention
Original: retatrutide
Retatrutide, an experimental weight-loss injection developed by Eli Lilly, is drawing widespread searches and media explainers in the US, UK and Australia. Outlets are walking readers through what the drug is, how it differs from existing GLP-1 treatments like Ozempic and tirzepatide, and what trial results suggest about its potential for obesity treatment.
Why now: Growing public interest in next-generation obesity drugs following attention on Eli Lilly's retatrutide.
Eli LillyretatrutideUnited StatesUnited KingdomAustralia
Rank over time, top of the chart is #1. 9 snapshots from 6 d ago to 6 d ago.
Evidence
Elsewhere
- GgoogleNL #8 · 1 d ago
- GgoogleIT #5 · 4 d ago
- GgoogleGB #6 · 6 d ago
- GgoogleUS #4 · 7 d ago
- GgoogleBR #7 · 20 d ago
API: https://socialmediatrends-api.osmike.com/v1/trends/2159712